In the nervous system, neural stem cells (NSCs) are necessary for the generation of new neurons and for cognitive function. Here we show that FoxO3, a member of a transcription factor family known to extend lifespan in invertebrates, regulates the NSC pool. We find that adult FoxO3 À/À mice have fewer NSCs in vivo than wild-type counterparts. NSCs isolated from adult FoxO3 À/À mice have decreased selfrenewal and an impaired ability to generate different neural lineages. Identification of the FoxO3-dependent gene expression profile in NSCs suggests that FoxO3 regulates the NSC pool by inducing a program of genes that preserves quiescence, prevents premature differentiation, and controls oxygen metabolism. The ability of FoxO3 to prevent the premature depletion of NSCs might have important implications for counteracting brain aging in long-lived species.
INTRODUCTION
Neural stem cells (NSCs) can self-renew and generate all three neural lineages of the nervous system: neurons, astrocytes, and oligodendrocytes. During embryonic and postnatal development, NSCs give rise to rapidly amplifying neural progenitors, which are responsible for the proper formation of the nervous system. The adult mammalian brain contains two residual populations of relatively quiescent NSCs in the subgranular zone (SGZ) of the dentate gyrus (DG) in the hippocampus and in the subventricular zone (SVZ) of the cortex (Alvarez-Buylla and Temple, 1998; Zhao et al., 2008) . In the adult brain, the generation of new neurons (neurogenesis) from NSCs is thought to play an important role in learning and memory, spatial pattern separation, and odor discrimination (Clelland et al., 2009; Gheusi et al., 2000; Imayoshi et al., 2008) . Both the number of NSCs and neurogenesis decline with age and this age-dependent decline is correlated with a gradual loss of cognitive and sensory functions (Bondolfi et al., 2004; Kempermann et al., 1998; Tropepe et al., 1997) . Conversely, the pool of NSCs, neurogenesis, and cognitive performance in adults are preserved in a strain of long-lived mutant mice (Kinney et al., 2001; Sun et al., 2005) . Thus, an intact pool of functional NSCs may be crucial for preserving cognitive functions throughout life.
The polycomb family member Bmi-1 has been recently found to play an important role in NSC self-renewal by negatively regulating the cell cycle inhibitor p21 CIP1 in embryonic NSCs (Fasano et al., 2007) , and p16 INK4a and p19 ARF in adult NSCs (Molofsky et al., 2005 (Molofsky et al., , 2006 . TLX, a nuclear receptor, also regulates NSC self-renewal during development and adulthood in a cell-autonomous manner (Zhang et al., 2008) . Other mechanisms to regulate the self-renewal and multipotency of NSCs throughout life remain largely unknown, but one intriguing possibility is that genes that regulate lifespan in invertebrates may have evolved to control stem cell pools in mammals. FoxO transcription factors are necessary for the extreme longevity of mutants of the insulin pathway in invertebrates (Kenyon, 2005) . In humans, single-nucleotide polymorphisms in one of the four FoxO genes, FoxO3, have recently been associated with extreme longevity (Flachsbart et al., 2009; Willcox et al., 2008) , raising the possibility that FoxO3 also regulates lifespan in mammals. FoxO factors can elicit a variety of cellular responses, including cell cycle arrest, differentiation, resistance to oxidative stress, and apoptosis (Salih and Brunet, 2008) . FoxO factors have recently been found to regulate the self-renewal of adult hematopoietic stem cells (HSCs), primarily by providing resistance to oxidative stress (Miyamoto et al., 2007; Tothova et al., 2007) . Whether and how FoxO transcription factors regulate NSCs is unknown.
FoxO transcription factors are inactivated in response to insulin or growth factors by phosphorylation by the protein kinase Akt, which results in their nuclear export (Salih and Brunet, 2008) . Activation of the PI3K-Akt pathway, for example by ablation of the gene encoding the PTEN phosphatase, promotes the self-renewal of neural progenitor cells (Groszer et al., 2006; Li et al., 2002; Sinor and Lillien, 2004) . However, the role of the PI3K-Akt pathway in the NSC pool in vivo has not been examined and the PI3K-Akt pathway has many other downstream targets in addition to FoxO factors.
Here we show that the transcription factor FoxO3, a member of a gene family that extends lifespan in invertebrates, is necessary for the regulation of the NSC pool in mice. We also identify the program of genes regulated by FoxO3 in NSCs. Our findings suggest that FoxO3 regulates the NSC pool by inducing a program that promotes quiescence, prevents premature differentiation, and controls oxygen metabolism. FoxO3's ability to regulate NSC homeostasis may protect normal cognitive function in organisms that live to an advanced age.
RESULTS

FoxO3 Is Expressed in Adult NSCs/Neural Progenitors In Vivo and In Vitro
To determine whether FoxO3 protein is expressed in NSC niches in the adult mouse brain, we used an antibody that recognized FoxO3 but did not significantly detect FoxO1, FoxO4, or FoxO6 in cells (Figures S1A-S1C available online). We stained brain sections of adult FoxO3 +/+ and FoxO3 À/À mice with this antibody and found that FoxO3 is expressed in both the SGZ and the SVZ ( Figure S2A ). Western blotting experiments confirmed that FoxO3 is highly expressed in NSC niches in vivo ( Figure S2B ). NSC niches contain NSCs, committed progenitors, and differentiated progeny. To determine whether FoxO3 is expressed in NSCs in vivo, we stained brain sections with antibodies to FoxO3 and to Sox2, a marker of NSCs/neural progenitors, or to NeuN, a marker of neurons ( Figure 1A ). These experiments revealed that FoxO3 is expressed in Sox2-positive cells in the SGZ and the SVZ ( Figure 1A ). FoxO3 is expressed in a subset of NeuN-negative cells ( Figure 1A , bottom, white arrows) and in Immunohistochemistry on brain sections of 3-month-old mice with antibodies to FoxO3 (''Ct''), Sox2, and NeuN in the dentate gyrus (DG) of the hippocampus and in the subventricular zone (SVZ) of Sox2-positive/FoxO3-positive and NeuN-negative/FoxO3-positive nuclei are shown by white arrowheads. Higher magnification images are included. Scale bar represents 100 mm.
(B) FoxO3 is expressed in purified NSCs in culture.
Immunocytochemistry on NSCs isolated from 3-month-old mice with antibodies to FoxO3 (''Ct'') and to Nestin. DAPI was used to stain nuclei. NSCs were either grown as neurospheres (whole NS) (left) or freshly dissociated NSCs (Diss. NSCs) (right). Scale bar represents 100 mm.
(C) FoxO3 expression in NSCs at different ages. Western blots of protein lysates from secondary neurospheres in self-renewing conditions from FoxO3 +/+ and FoxO3 À/À littermates at three different ages, 1-day-old (1d), 3-month-old (3m), and 1-year-old (1y), probed with antibodies to FoxO3 (''NFL'') and to b-actin. The data presented are representative of three independent experiments.
(D) FoxO3 phosphorylation is increased in differentiated progeny. Western blots of protein lysates of dissociated wild-type adult NSCs in self-renewing conditions (day 0) or in differentiation conditions for increasing lengths of time (days 1-6) ( Figure S3B ). Western blots were probed with antibodies to FoxO3 (''NFL''), to Phospho-T32 (FoxO3 T32-P) and to b-actin. Blots representative of three independent experiments. (E) A FoxO-dependent reporter gene is responsive to FoxO3 in NSCs. Luciferase assays in wild-type adult NSCs with a promoter containing three FoxO binding sites driving the luciferase reporter gene (FHRE pGL3) or a control promoter (pGL3) and FoxO3 expression vectors (minus sign, empty vector; WT, wild-type; CA, constitutively active; I, inactive). Values represent mean ± SEM from three independent experiments. One-way ANOVA, Bonferroni posttests, *p < 0.05, **p < 0.01, ***p < 0.001. (F) Endogenous FoxO3 is active in self-renewing NSCs. Luciferase assays in FoxO3 +/+ and FoxO3 À/À adult NSCs with FHRE pGL3 or control pGL3 as in (E).
Values were normalized to the first column. Values represent mean ± SEM from three independent experiments. One-way ANOVA, Bonferroni posttests, **p < 0.01, ***p < 0.001.
bromodeoxyuridine (BrdU)-positive label-retaining cells, which are thought to be NSCs ( Figure S2C ; see Figure 2 ). These results indicate that FoxO3 is expressed in adult NSCs, as well as in other cells in the NSC niches. The fact that FoxO3 staining overlaps with the nuclear staining of Sox2 and BrdU further suggests that FoxO3 is nuclear in adult NSCs and therefore likely to be active in these cells ( Figure 1A ; Figure S2C ).
To confirm that FoxO3 is expressed in NSCs, we isolated NSCs from both the DG and the SVZ regions of the postnatal or adult mouse brain. Mouse NSCs form clonal spheres called neurospheres, which are composed of NSCs and more committed neural progenitors (Reynolds and Weiss, 1992) . Immunostaining experiments on whole neurospheres or on dissociated NSCs revealed that FoxO3 is expressed in Figure S4A ). The number of BrdU-positive cells in the SGZ was normalized to the volume of the granular cell layer (GCL) ( Figure S4C -year-old [1y] ). Values represent mean ± SEM from 4-6 mice (1d), 20-23 males and 6-9 females (3m), and 4-7 males and females (1y). Mann-Whitney test, *p < 0.05; **p < 0.01; ***p < 0.001.
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FoxO3 Regulates Neural Stem Cell Homeostasis NSCs/progenitors derived from both postnatal and adult animals and is coexpressed with Nestin, a NSC/progenitor marker (Figure 1B ; Figure S3A ). To quantify the levels of FoxO3 in NSCs as a function of age, we used western blotting on protein extracts of neurospheres from NSCs isolated from mice at three different age milestones: birth (1-day-old), adulthood (3-month-old), and middle age (1-year-old). These experiments confirmed that FoxO3 is expressed in NSCs from mice at all ages ( Figure 1C ). FoxO3 protein expression is lower in NSCs from neonates than in NSCs from adults, but there was no significant change in FoxO3 expression in NSCs from young versus middle-aged adults ( Figure 1C ). Thus, FoxO3 is expressed in NSCs/progenitors from both developing and adult mice, with higher expression in adult NSCs.
FoxO3 Activity Is Higher in Self-Renewing NSCs than in Differentiated Progeny
To assess FoxO3 activity in NSCs, we compared the phosphorylation status of FoxO3 in self-renewing versus differentiating adult NSCs via western blotting with phospho-specific antibodies to Threonine 32 (T32), one of the three sites of FoxO3 phosphorylated by Akt (Brunet et al., 1999) . A larger percentage of FoxO3 was phosphorylated at T32 in differentiated progeny than in self-renewing NSCs ( Figure 1D ; Figure S3B ). As T32 phosphorylation is correlated with FoxO3 inactivation (Brunet et al., 1999) , these results suggest that FoxO3 is more active in self-renewing NSCs than in their differentiated progeny.
To quantify FoxO3 activity in NSCs, we performed luciferase assays by using a luciferase reporter gene under the control of three Forkhead binding sites (Brunet et al., 1999) . We first verified that this FoxO reporter gene was responsive to FoxO3 in NSCs by transfecting wild-type adult NSCs with active or inactive forms of FoxO3 ( Figure 1E ). We next tested the activity of endogenous FoxO3 in NSCs and found that this FoxO reporter gene was active in adult FoxO3 +/+ NSCs and that its activity was significantly decreased in FoxO3 À/À NSCs ( Figure 1F ). (Figure 2 ). FoxO3 À/À mice are viable and normal in outward appearance, though they are prone to cancer and die at around 1 to 1.5 years of age (data not shown; Paik et al., 2007) . BrdU was injected daily into adult FoxO3 À/À and FoxO3 +/+ littermates for 7 days and the mice were sacrificed either 1 month ( Figure 2A ) or 1 day ( Figure 2D ) after the last BrdU injection. We counted BrdU-positive cells in the NSC niches 1 month after the last BrdU injection (Figures 2B and 2C ; Figure S4A ). These label-retaining cells are thought to be the relatively quiescent NSCs that remain in NSC niches whereas neural progenitors and differentiated cells migrate away from NSC niches (Bondolfi et al., 2004) . FoxO3 À/À mice displayed a significant reduction in the number of label-retaining NSCs compared to FoxO3 +/+ mice in both the SGZ ( Figure 2B , left) and the SVZ (Figures 2B, right, and Figure S4A ). This result suggests that in the absence of FoxO3, adult mice have fewer NSCs. In contrast, when mice were sacrificed 1 day after the BrdU injections ( Figure 2D ), FoxO3 À/À mice tended to have more BrdU-positive cells than FoxO3 +/+ mice in the SGZ (p = 0.40) and the SVZ (p = 0.10) ( Figure 2E ). BrdU-positive cells in the short-term BrdU paradigm are mostly neural progenitors, so these results indicate that in FoxO3 À/À mice, the number of progenitors is not decreased and may even be slightly increased. Consistent with this finding, brains from adult FoxO3 À/À mice were significantly heavier than brains from wild-type counterparts. In contrast, brains from FoxO3 À/À mice had similar weight as wild-type counterparts at birth ( Figure 2F ). Together, these results suggest that FoxO3 loss may lead to the short-term amplification of progenitors, resulting in the exhaustion of the NSC pool over time. Figure 3B ; Figure S5A ) formed primary neurospheres with the same frequency as FoxO3 +/+ NSCs. In contrast, FoxO3 À/À NSCs isolated from both young adult mice and middle-aged mice formed neurospheres at a significantly lower frequency than FoxO3 +/+ NSCs ( Figure 3B ; Figure S5B ). These results indicate that the absence of FoxO3 leads to defects in the NSC pool that are evident only in adult mice. Because FoxO3 is constitutively deleted in FoxO3 À/À mice, it is not possible to distinguish whether FoxO3 regulates the NSC pool only in adults or whether FoxO3 also acts in NSCs during embryonic and/or postnatal development. As previously reported (Molofsky et al., 2006) , the frequency of primary neurospheres formed in culture decreased significantly with the age of the mice ( Figure 3B ). The absence of FoxO3 did not have a greater impact on NSCs from middle-aged mice than in NSCs from young adult mice ( Figure 3B ), which might be due to a progressive inactivation of FoxO3 function during aging. neurospheres, and the number of secondary neurospheres formed can serve as a measure of NSC self-renewal (Kippin et al., 2005 Figure 4B ). FoxO3 À/À NSCs from middle-aged mice tended to form fewer neurospheres containing both neurons and astrocytes and more neurospheres containing only astrocytes compared to FoxO3 +/+ NSCs ( Figures 4C and 4D ). Similar results were obtained when differentiated neurospheres were stained for all three cell fates simultaneously ( Figure S6 ). These findings indicate that FoxO3 loss results in a deficiency in the ability of NSCs to generate different neural lineages that is evident only in adulthood. Our observations further suggest that in the 
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FoxO3 Regulates Neural Stem Cell Homeostasis absence of FoxO3, NSCs become more similar to progenitors (i.e., less able to self-renew and more committed to a specific lineage). NSCs lacking FoxO3 also resemble NSCs from older animals, which are less able to self-renew and more skewed toward astrocytes (Bondolfi et al., 2004) .
FoxO3 Acts in the Nervous System to Regulate the NSC Pool
FoxO3 is expressed in a number of tissues, raising the question of whether FoxO3 regulates the NSC pool by acting in the brain or in other tissues, which could in turn affect NSCs. To address this question, we crossed FoxO3 lox/lox mice with Nestin-Cre transgenic mice, which express the Cre recombinase in NSCs/ progenitors from embryonic day 10.5 (Tronche et al., 1999) . As expected, FoxO3 lox/lox ;Nestin-Cre mice displayed an ablation of the FoxO3 protein in the brain, but not in the majority of other tissues ( Figure 5A ). Interestingly, young and middle-aged adult FoxO3 lox/lox ;Nestin-Cre mice had significantly heavier brains than their control siblings ( Figure 5B ). These results suggest that FoxO3 regulates brain weight by acting in the nervous system, rather than in other tissues.
To test whether FoxO3 regulates the NSC pool by acting in the nervous system, we performed BrdU long-term retention experiments in vivo in FoxO3 lox/lox ;Nestin-Cre mice and FoxO3 lox/lox siblings ( Figure 5C ). We found that young adult FoxO3 lox/lox ;
Nestin-Cre mice tended to have fewer label-retaining NSCs in the SVZ and in the SGZ than control siblings, though this did not reach statistical significance ( Figure 5C ). Nestin-Cre mice had no FoxO3 protein expression for up to four passages ( Figure 5D ), indicating that the deletion of the FoxO3 gene was efficient. Interestingly, NSCs isolated from 9-month-old FoxO3 lox/lox ;Nestin-Cre mice displayed significant defects in their ability to form primary neurospheres compared to NSCs isolated from control FoxO3 lox/lox littermates ( Figure 5E ). Together, these results suggest that FoxO3 acts in the nervous system to regulate adult brain weight and NSC homeostasis in vivo. Because FoxO3 is deleted from embryonic day 10.5 in Figure 2F ), suggests that cell death is not a major consequence of FoxO3 loss and that loss of quiescence may play a more important role in the depletion of NSCs in vivo in FoxO3 À/À mice.
FoxO3 Coordinates the Expression of a Specific Program of Genes in NSCs
To gain insight into the molecular mechanisms by which FoxO3 regulates NSCs, we determined the program of genes regulated by FoxO3 in NSCs. We performed a genome-wide microarray analysis on RNA isolated from two independent biological replicates, each in duplicate, of FoxO3 À/À and FoxO3 +/+ secondary neurospheres from young adult mice. We used secondary neurospheres because FoxO3 À/À and FoxO3 +/+ neurospheres displayed a significant difference in self-renewal ability. Analysis of the microarray data revealed that the expression of a specific subset of genes is decreased in FoxO3 À/À neurospheres compared to FoxO3 +/+ neurospheres (Figures 7A and 7B; Table   S1 ). The changes in expression levels of a number of these genes were validated by reverse transcription followed by quantitative PCR ( Figure S7 ). The analysis of our microarray data revealed that FoxO3 is required for the expression of genes involved in cell quiescence, as was previously shown in other cell types (Salih and Brunet, 2008) . For example, FoxO3 is necessary for the expression of p27 KIP1 and Cyclin G2 ( Figure 7A ; Figure S7 ). The comparison of our microarray data with available molecular signatures revealed that FoxO3-regulated genes were significantly enriched for genes that form a molecular signature for quiescence (Figure 7C ; Figures S8A and S8B) . These results support the notion that FoxO3 regulates the homeostasis of the NSC pool by preventing the premature overproliferation of progenitors and preserving the relative quiescence of NSCs. We also found that FoxO3 was necessary for the expression of genes involved in oxidative stress resistance (e.g., selenbp1) ( Figure 7A ; Figure S7 ) and in glucose metabolism and transport (e.g., Pdk1, Slc2a3) (Figures 7A and 7C ; Figure S7 ), consistent with the known role of the FoxO family in stress resistance and cellular metabolism (Accili and Arden, 2004) . The ability of FoxO3 to coordinate a program maintaining quiescence, stress resistance, and glucose metabolism in adult NSCs may be critical for preserving the stemness of these cells.
Interestingly, we also identified genes that were not previously known to be upregulated by FoxO factors. First, FoxO3 was necessary for the upregulation of genes involved in early neurogenesis (e.g., Otx2) ( Figure 7A ; Figure S7 ), which may contribute to the defect in multipotency of FoxO3 À/À neurospheres (Figure S6) . Surprisingly, the comparison between our microarray data and publicly available molecular signatures revealed that FoxO3 was necessary for the expression of genes upregulated in hypoxic brains and other hypoxic tissues, including Ddit4, Ndrg1, Ero1l, and Vegfa (Figures 7A and 7C ; Figures S7, S8C, and S8D; Table S1 ). These findings raise the possibility that FoxO3 is necessary for the response of NSCs to low oxygen. The ability of FoxO3 to control oxygen metabolism in NSCs may participate in the regulation of NSCs in vivo. FoxO3 is also required for the repression of specific genes in neurospheres ( Figure 7B ). For example, genes expressed in mature oligodendrocytes, including Myelin Basic Protein, Plp1, and Apod, were upregulated in FoxO3 À/À NSCs compared to FoxO3 +/+ NSCs ( Figure 7B ; Figure S7 ; Table S1 ). These results suggest that FoxO3 normally prevents premature oligodendrocyte differentiation. Consistent with these findings, we observed that the corpus callosum area, a brain structure that contains mature oligodendrocytes, is increased in adult FoxO3 À/À mice compared to FoxO3 +/+ littermates ( Figure S9 ). The inhibition of the premature differentiation of NSCs by FoxO3 may contribute to the functionality of NSCs in vivo.
Finally, the comparison of our microarray data with genes that are known to change during aging in human and mouse brains revealed a correlation between FoxO3-regulated genes and genes that are regulated during aging in the brain ( Figure 7C ; Figures S8E and S8F ). These observations are consistent with the possibility that FoxO3, a gene that belongs to a family that promotes longevity in invertebrates, also regulates genes that are important to counteract the aging process in mammalian adult stem cells.
Identification of FoxO3 Direct Targets in NSCs
FoxO3-regulated genes are enriched for the presence of a FoxO binding motif in their regulatory regions ( Figure 7A ; Table S1 ), raising the possibility that a subset of FoxO3-regulated genes might be direct FoxO3 target genes in NSCs. To identify direct targets of FoxO3, we performed electrophoretic mobility shift Cell Stem Cell Brain weights were measured after perfusion in 3-to 4-month-old mice (3-4m) and 1.6-year-old mice (1.6y). Values represent mean ± SEM from nine to ten males and nine to ten females (3-4m), and one to three males and five to eight females (1.6y). One male and two females (3-4m) and three females (1. Figure 7D ; Figure S10C ). These results indicate that p27
KIP1
, a cell cycle inhibitor involved in cell quiescence and Ddit4, a known target of hypoxia-inducible factor 1 (HIF1), are direct target genes of FoxO3 in NSCs. In contrast, FoxO3 was not bound at the promoters of Otx2 and Ndrg1 by ChIP (data not shown), suggesting that these two genes may not be direct FoxO3 targets in NSCs.
The Response of FoxO3
À/À NSCs to Low Oxygen Is Impaired In Vitro Because a subset of FoxO3-regulated genes is involved in the cellular response to hypoxia, we compared the ability of FoxO3 +/+ and FoxO3 À/À NSCs to form neurospheres in lowoxygen (2%) versus atmospheric oxygen (20%) conditions ( Figure 7E ). Consistent with published findings for embryonic NSCs/progenitors (Studer et al., 2000) , adult NSCs showed an increased ability to form neurospheres in low oxygen compared to atmospheric oxygen ( Figure 7E ). In contrast, FoxO3 À/À NSCs did not display an increased ability to form neurospheres in lowoxygen compared to atmospheric oxygen conditions ( Figure 7E ). These results suggest that the response of FoxO3 À/À NSCs to low oxygen is impaired in vitro. It is also possible that 2% oxygen, which mimics in vivo physiological oxygen concentrations in the mammalian brain (Zhu et al., 2005) , helps reveal differences between FoxO3 À/À and FoxO3 +/+ NSCs. Together, these results indicate that FoxO3 is necessary for the expression of a program of genes that coordinate cell quiescence, inhibition of premature differentiation, and oxygen metabolism, which may all contribute to the ability of FoxO3 to regulate the homeostasis of the NSC pool.
DISCUSSION
Our results indicate that FoxO3 regulates processes and pathways relevant to NSC homeostasis both in vitro and in vivo. In the absence of FoxO3, NSCs display a decreased ability to self-renew and to give rise to different neural lineages, which may result in the depletion of NSCs in vivo. Our findings also suggest that FoxO3 regulates NSC homeostasis by controlling a program of genes that precisely governs cell cycle re-entry and promotes a state of glucose and oxygen metabolism compatible with optimal self-renewal. Because the NSC pool is a limited reserve that needs to be maintained throughout life, preserving this pool may be an important factor in the healthspan of long-lived organisms.
The effects of FoxO3 loss on NSCs manifest themselves only in adult animals. This observation raises the possibility that FoxO3 plays a more important role in adult NSCs than in embryonic or neonatal NSCs. It is also possible that FoxO3 acts to alter embryonic or postnatal NSC biology or the NSC niche, which would ultimately result in the depletion of adult NSCs later in life. Alternatively, FoxO3 loss may be better compensated by other FoxO family members in embryonic and postnatal NSCs than in adult NSCs. Precisely studying the timing of action of FoxO3 in NSCs will require crossing FoxO3 lox/lox mice with mice expressing a tamoxifen-inducible form of Cre (CreER) driven from promoters that are active in NSCs, such as Nestin, GFAP, Glast, or TLX (Johnson et al., 2009) . Our experiments indicate that FoxO3 exerts at least part of its action in the nervous system to regulate brain weight and the NSC pool. FoxO3 may also act in part in the stem cell niche or systemically to regulate NSCs. FoxO3 is expressed in neurons, astrocytes, and oligodendrocytes, as well as in endothelial cells of the vasculature, all of which may contribute to the NSC niche. Because FoxO3 has been shown to play an important role in specific endothelial cells (Paik et al., 2007) , a portion of the defect observed in the brain of FoxO3 À/À mice might come from FoxO3 loss in blood vessels. A rigorous demonstration of the cell autonomy of FoxO3 will require the generation of mouse models in which FoxO3 is specifically deleted in NSCs. Nevertheless, the observation that FoxO3 lox/lox ;Nestin-Cre mice (this study) and (1) (2) (3) (4) (5) (6) (7) (8)
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(10) Figure S10C ). Our findings suggest that FoxO3 is necessary for the expression of hypoxia-dependent genes in NSCs, several of which are known to be targets of the hypoxia-inducible factor HIF1. In C. elegans, the FoxO transcription factor DAF-16 and HIF1 also share common target genes (McElwee et al., 2004) . However, in other mammalian cells, FoxO3 inhibits hypoxiadependent genes in an indirect manner (Bakker et al., 2007; Emerling et al., 2008) . Thus, FoxO3 may both directly regulate some HIF1 target genes and indirectly inhibit HIF1-dependent transcription. The balance between these two functions of FoxO3 could be altered by variations in the levels of oxygen. Alternatively, the regulation of the hypoxic program may differ, depending on the types of cells or tissues. The finding that FoxO3 is required for the expression of genes that mediate the response to hypoxia in NSCs is consistent with the observation that hypoxia and HIF1 promote self-renewal and multipotency in stem cells (Keith and Simon, 2007) . NSCs are located in close proximity to blood vessels in vivo and may be subjected to varying levels of oxygen (Mirzadeh et al., 2008; Shen et al., 2008; Tavazoie et al., 2008) , so the ability of FoxO3 to regulate oxygen metabolism in NSCs might also play a role in the protection of these cells in vivo.
In conclusion, our findings suggest that a gene identified based on its function in regulating lifespan in invertebrates may have evolved to play a critical role in regulating NSC homeostasis in mammals. Because NSCs have been shown to be important for learning, memory, and mood regulation, our findings could give insight into the decline in cognitive function that occurs during aging.
EXPERIMENTAL PROCEDURES
Materials and other experimental procedures are described in the Supplemental Data.
Animals
FoxO3
À/À and FoxO3 lox/lox mice in the FVB/N background were generously provided by Dr. Ron DePinho (Dana Farber Cancer, Boston). Nestin-Cre mice in the C57/Bl6 background were purchased from Jackson Laboratories. All care and procedures were in accordance with the Guide for the Care and Use of Laboratory Animals. All animal experiments were approved by Stanford's Administrative Panel on Laboratory Animal Care (APLAC) and in accordance with institutional and national guidelines.
Quantification of BrdU-Positive NSCs and Progenitors In Vivo
Mice were injected intraperitoneally with 50 mg/kg of BrdU (EMD Biosciences) once a day for 7 days and sacrificed either 1 day or 1 month later. Mice were anesthetized and perfused transcardially with PBS containing 5 U/ml of heparin, then with 4% paraformaldehyde (PFA). Brains were fixed in 4% PFA for 4 hr at 4 C, then in 30% sucrose/4% PFA overnight at 4 C, and embedded in Tissue-Tek (Sakura) at À80 C. Coronal sections (40 mm) were cut with a microtome. Sections were incubated in 3% H 2 O 2 for 30 min, in 2 N HCl solution for 30 min at 37 C, followed by washes in boric acid buffer (pH 8.4).
Sections were incubated with the BrdU antibody (AbD serotec, 1:500) overnight at 4 C, and then with the secondary antibody (biotinylated donkey anti-rat, Jackson ImmunoResearch, 1:500) overnight at 4 C. The sections were then incubated in the ABC solution (Vector Laboratories) for 90 min, and with DAB (Sigma, 0.05%) containing 0.15% H 2 O 2 for 2-10 min. The sections were dried, dehydrated on slides, and mounted with Permount (Fisher Scientific). BrdU staining and quantification was performed on every sixth section from Bregma +1.54 mm to À1.34 mm (SVZ) and from Bregma À0.94 mm to À3.88 mm (DG). BrdU-positive cells were counted in a blinded manner. The total number of BrdU-positive cells in each region was obtained by multiplying the number of BrdU-positive nuclei by 6. In the DG, the number of BrdU-positive cells was normalized by the granular cell layer (GCL) volume (in mm 3 ). The GCL volume was quantified on every sixth section by calculating the area of the GCL on both sides via Metamorph (Molecular Devices). The total GCL volume was estimated by multiplying these areas by 6 and then by 40 mm.
Mouse NSC Cultures
Isolation of mouse NSCs/progenitors was done as described previously (Palmer et al., 1997) . In brief, the brains were dissected to remove the olfactory bulbs, cerebellum, and brainstem. The forebrains were finely minced; digested for 30 min at 37 C in HBSS media containing 2.5 U/ml Papain (Worthington), 1 U/ml Dispase (Roche), and 250 U/ml DNase I (Sigma); and mechanically dissociated. NSCs/progenitors were purified with two Percoll gradients (25% then 65%) (Amersham) and plated at a density of 10 5 cells/cm 2 in NeuroBasal-A medium with penicillin-streptomycin-glutamine (Invitrogen), B27 supplement (Invitrogen, 2%), bFGF (Peprotech, 20 ng/ml), and EGF (Peprotech, 20 ng/ml) (self-renewal/proliferation media). Cells were incubated at 37 C in 5% CO 2 and 20% oxygen at 95% humidity.
(E) FoxO3 À/À NSCs form fewer neurospheres than FoxO3 +/+ NSCs in low-oxygen conditions. Normalized frequency of neurospheres formed from NSCs at low density in 20% oxygen (20) or in 2% oxygen (2). NSCs were dissociated from secondary neurospheres generated from 3-month-old FoxO3 À/À and FoxO3
mice. Values represent mean ± SEM from four independent experiments with three to five littermates for each genotype. The normalization was done by dividing the triplicate average from each experiment in 2% oxygen by the triplicate average from the same experiment in 20% oxygen. Two-way ANOVA, Bonferroni posttests, *p < 0.05; **p < 0.01.
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Primary and Secondary Neurosphere Assays At isolation, NSCs were plated in triplicate at low density (1 to 32,000 cells/ml) into a 24-well plate in self-renewal/proliferation media and the number of primary neurospheres formed was assessed in a blinded manner after 7 days. Primary neurospheres were dissociated with Accutase (Chemicon) and plated in triplicate at low density (1 to 4000 cells/ml) into a 24-well plate in self-renewal/proliferation media and the number of secondary neurospheres formed was assessed after 7 days. For moderate hypoxia (2%), cell culture dishes were placed into an Invivo 2 humidified hypoxia workstation (Ruskinn Technologies, Bridgend, UK).
NSC Ability to Generate Different Neural Lineages
Secondary neurospheres from self-renewal assays were plated onto acidtreated glass coverslips (Bellco) coated with poly-D-lysine (Sigma, 50 mg/ml) and incubated in differentiation media (NeuroBasal-A medium supplemented with penicillin-streptomycin-glutamine, B27 supplement, and 1% fetal bovine serum [Invitrogen] ). Differentiated neurospheres were fixed in 4% PFA and then stained with antibodies to Tuj1 (Covance, 1:1000) or to GFAP (guinea pig, Advanced Immunochemicals Inc., 1:1000). Alternatively, neurospheres were incubated with the antibody to O4 (a gift from Ben Barres, 1:1 in 10% goat serum/1% BSA/0.1 M L-lysine) before fixation. Secondary antibodies (Molecular Probes) were used at a dilution of 1:400. For quantification, three coverslips containing 50 whole neurospheres per coverslip were counted in a blinded manner. 
Microarray Analysis
ACCESSION NUMBERS
Microarray data were deposited at the Gene Expression Omnibus (GEO) database under the accession number GSE18326. respectively. Antibodies to phospho-T32 and to FoxO3 ('NFL' and 'Ct') were described previously (Brunet et al., 1999; Greer et al., 2007) . 'NFL' is directed to full length human FoxO3. 'Ct' is directed to amino-acids 497 to 601 of mouse FoxO3.
SUPPLEMENTAL DATA
Immunohistochemistry on mouse brain sections
Mice were anesthetized and perfused transcardially with PBS containing 5 U/ml 
Western blotting
NSC protein extracts were obtained by lysing NSC in lysis buffer (Tris HCl pH 8.0
(50 mM), NaCl (100 mM), EGTA (2 mM), NaF (10 mM), β-glycerophosphate (40 mM), Triton-X100 (0.4%), aprotinin (10 µg/ml), phenylmethylsulfonyl fluoride (PMSF, 1 mM)). Tissue protein extracts were obtained by lysing tissues in RIPA buffer (Tris-HCl pH 8.0 (50 mM), NaCl (150 mM), EDTA (1 mM), NP-40 (1%), Na-deoxycholate (0.25%), PMSF (10 mM), Aprotinin (10 µg/ml), NaF (10 mM), β-glycerophosphate (40 mM)). Thirty μg of proteins was resolved on SDS-PAGE (10%) and transferred onto nitrocellulose membranes. The membranes were incubated with primary antibodies and the primary antibody was visualized using 3 HRP-conjugated anti-mouse or anti-rabbit secondary antibodies and enhanced chemiluminescence (ECL, Amersham).
Luciferase assays
NSC at early passages were seeded at 10 5 cells/ml in poly-D-lysine-coated 24-well plates. The next day, NSC were transfected using Lipofectamine (Invitrogen) with 200 ng of a luciferase reporter construct driven by three tandem repeats of the FoxO binding element contained in the FasL promoter (FHRE pGL3) (Brunet et al., 1999) , 200 ng of a Renilla luciferase reporter construct (pRL0), and for the positive controls, 200 ng of FoxO3 constructs in pECE plasmids (Brunet et al., 1999) . Forty-eight hours after transfection, cells were lysed and luciferase and renilla luciferase activities were measured using the Dual Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol.
BrdU and cleaved caspase 3 immunocytochemistry
Freshly dissociated NSC were plated onto acid-treated glass coverslips (Bellco) coated with poly-D-lysine (Sigma, 50 µg/ml) at a density of 5 x 10 4 cells/ml in 24-well dishes. Twenty-four hours later, BrdU (10 μM) was added for 1 hr and the cells were fixed in 4% PFA and permeabilized in 0.4%Triton for 30 min. 
Chromatin Immunoprecipitation
NSC from 3 month-old mice were plated at a density of 1 x 10 5 cells/ml. Twenty four hours later, dissociated NSC were switched to medium without EGF and bFGF for 4 hours and treated with 20 μM LY294002 (Calbiochem) for 1 hour to activate endogenous FoxO3 (Brunet et al., 1999) . Cells were crosslinked with 1%
PFA for 10 min. Crosslinking was stopped with 0.125 M glycine for 5 min. NSC were resuspended in swelling buffer (HEPES pH 7.8 (10 mM), MgCl 2 (1.5 mM),
KCl (10 mM Chromatin was cleared by centrifugation at 14,000 rpm for 15 min at 4 o C.
Immunoprecipitation was done as described (Mortazavi et al., 2006) . Standard curves were calculated for each primer set using a serial dilution of the input, and were in turn used to determine fold enrichment relative to the IgG control ChIP.
FoxO3 antibody specificity
HEK293T cells were transfected with empty vector or with myc-tagged mouse FoxO family members (FoxO1, FoxO3, FoxO4 and FoxO6 in pcDNA4.1). Briefly, 2.5 μg of DNA was transfected in each well of a 12-well plate (350,000 cells per well) using the calcium phosphate method. Forty eight hours after plating, cells were fixed in 4% PFA and permeabilized with 0.1% Triton X-100 for 30 min.
Coverslips were incubated with antibodies to FoxO3 ('Ct'; 1:500) or to myc
(1:500) for 2 hours and washed with PBS. Cells were then incubated for 1 hr with
Texas Red goat anti-rabbit antibodies or FITC goat anti-mouse antibodies (1:400, 7 Molecular Probes). Coverslips were mounted in Vectashield containing DAPI.
Pictures were taken randomly using a fluorescent microscope and AxioVision 4 software (Zeiss).
Multipotency assay
After 7 days in a neurosphere assay (low cell plating density, 1 to 4,000 cells/ml), secondary or tertiary neurospheres were collected and transferred onto acidtreated glass coverslips coated with poly-D-lysine (50 µg/ml) in 24-well plate.
Neurosphere differentiation was induced by incubation in differentiation medium (NeuroBasal-A medium supplemented with penicillin-streptomycin-glutamine, B27 supplement (2%) and 1% Fetal Bovine Serum (FBS)) for 7 days.
Differentiation medium was changed every other day for a week. To simultaneously determine the ability of neurospheres to differentiate into astrocytes, neurons and oligodendrocytes, unfixed differentiated neurospheres were incubated with the antibody to O4 (1:1 in 10% goat serum/1% BSA/0.1M Llysine) for 2 hrs at room temperature before fixation using 4% PFA for 15 min.
Neurospheres were the incubated with secondary antibodies (biotinylated donkey anti-mouse, 1:400, Jackson Immunologicals) for 1 hr at room temperature, followed by an incubation with the ABC system (Vector Laboratories) for 30 min at room temperature, and the reaction with the DAB solution (Sigma, 0.05%) containing 0.015% H 2 O 2 for 10 min. Differentiated neurospheres were next stained with antibodies to Tuj1 (1:1,000) and GFAP (guinea pig, 1:1,000).
Secondary antibodies (Alexa 488 goat anti-rabbit and goat anti-guinea pig, 8 Molecular Probes) were used at a dilution of 1:400. The coverslips were mounted on slides using Vectashield containing DAPI (Vector laboratories) and examined under epifluorescent illumination using a Zeiss microscope digital camera with AxioVision 4 software. For quantification, 20 to 50 whole neurospheres were counted in a blinded manner.
Reverse-transcription followed by quantitative PCR
The expression of mouse transcripts was determined by reverse transcription of total RNA followed by quantitative PCR analysis (RT-qPCR). After a DNAse treatment, 2 μg of total RNA was reverse transcribed (High Capacity Reverse
Transcription kit, Applied Biosystems) according to the manufacturer's protocol.
Real-time PCR was performed on a Bio-rad iCycler using iQ SYBR Green mix The experiments were conducted in triplicate and the results were expressed as 2 -(Gene of interest Ct-β-actin Ct) . Control PCR reactions were also performed on total RNA that had not been reverse-transcribed to test for the presence of genomic DNA in the RNA preparation.
Histopathology
Histopathology was performed on 3 month-old 
Electrophoretic Mobility Shift Assay
Electrophoretic mobility shift assays were performed as described (Greer et al., 2007) . Briefly, the forward and reverse oligonucleotides surrounding The double-stranded probes were purified from a 15% native gel. 10,000 cpm of labeled probes were incubated for 20 min at room temperature with 100-500 ng of recombinant GST-FoxO3 protein and 6 μg of salmon sperm DNA in electrophoretic mobility shift assay binding buffer (Tris-HCl, pH 7.5 (50 mM), KCl (250 mM), dithiothreitol (5 mM), MgCl 2 (25 mM), glycerol (50%), and Nonidet P-40 (0.25%)). The reactions were then resolved by electrophoresis on 4% native acrylamide gels. Gels were dried and autoradiographed. DG, and cortex isolated from adult wild-type brain probed with antibodies to FoxO3 ('NFL'), to phospho-Threonine 32 (FoxO3 T32-P: filled arrowhead), and to GAPDH as a loading control. The T32-P antibodies recognize a band of lower molecular weight in these brain tissues, which likely corresponds to another FoxO family member (empty arrowhead), as this phosphorylation site and the surrounding amino-acids are conserved in other FoxO family members and as this band is still seen in FoxO3 -/-extracts (data not shown). Note that in protein extracts from dissected brain regions, it is not possible to distinguish NSC from progenitors and differentiating progeny. (C) FoxO3 is expressed in BrdU-positive label-retaining NSC in vivo. Immunohistochemistry with antibodies to FoxO3 ('Ct'), to NeuN, and to BrdU in the DG and SVZ of 3 month-old mice one month after 7 days of daily BrdU injections. BrdU-positive/NeuN-negative/FoxO3-positive nuclei in the SGZ and in the SVZ are shown by white arrowheads. Scale bar: 100 µm. +/+ and FoxO3 -/-littermate neonate mice with antibodies to FoxO3 ('NFL') and to Nestin (NSC/progenitor marker). NSC were either grown as neurospheres (whole NS) (top panels) or freshly dissociated NSC (Diss. NSC) (bottom panels). Note that there is remaining staining in FoxO3 -/-NSC that is likely background staining. Similar results were obtained with adult NSC. Scale bars: 200 µm. (B) Differentiation marker expression during NSC differentiation. Western blots of protein lysates of dissociated wild-type NSC in self-renewal conditions (day 0) or in differentiation conditions for increasing lengths of time (day 1-6). Western blots were probed with antibodies to Tuj1 (neurons), GFAP (astrocytes), CNPase (oligodendrocytes), and β-actin as a loading control, to verify that NSC differentiated under these conditions. -/-NSC from middle-aged adult mice, but not from neonate mice, display a defect in primary neurosphere formation. NSC freshly isolated from FoxO3 +/+ or FoxO3 -/-littermates at two different ages were seeded in triplicate at a density of 1,000 to 32,000 cells/ml and the number of neurospheres formed 22 after one week was counted. (A) 1 day-old. Values represent mean ± SD of 2 independent experiments conducted with two littermates for each genotype. Twoway ANOVA, p=0.9766 for the genotype variable; (B) 1 year-old. Values represent mean ± SD of 3 independent experiments conducted with 3 to 5 littermates for each genotype. Two-way ANOVA, p<0.0001 for the genotype variable, Bonferroni post-tests, **: p<0.01; ***: p<0.001. (C-E) Adult FoxO3 -/-NSC display a defect in secondary neurosphere formation. Dissociated primary neurospheres formed after NSC isolation from FoxO3 +/+ or FoxO3 -/-littermates at 3 different ages (1 day-old, C; 3 month-old, D; 1 year-old, E), were seeded at 1,000 to 4,000 cells/ml and the number of secondary neurospheres formed after one week was counted. Values represent mean ± SEM of 2 independent experiments with two littermates (C), 4 independent experiments with 5 littermates (D), and 4 independent experiments with 3-5 littermates (E) for each genotype. Two-way ANOVA, p=0.3587 (C), p=0.0028 (D), and p=0.0004 (E) for the genotype variable, Bonferroni post-tests, *: p<0.05. (F) Self-renewal is not affected at later passages in FoxO3 -/-NSC versus FoxO3 +/+ NSC. NSC from 3 month-old FoxO3 +/+ or FoxO3 -/-littermates were seeded at a density of 1,000 to 4,000 cells/ml, and the number of neurospheres formed after one week was counted. Values represent mean ± SEM of 2 independent experiments conducted with 5 littermates for each genotype. Two-way ANOVA, p=0.5501 for the genotype variable. +/+ and FoxO3 -/-NSC from 9 month-old mice were grown as secondary or tertiary neurospheres at low density and placed in differentiation medium for 7 days. Neurospheres were stained simultaneously with antibodies to Tuj1 (neurons), GFAP (astrocytes), and O4 (oligodendrocytes). A multipotent neurosphere (Tuj1-positive/GFAP-positive/O4-positive) is shown. (B) Neurospheres that contained all three types of progeny (Tuj1+/GFAP+/O4+), two types of progeny (Tuj1+/GFAP+ or O4+/GFAP+), or just one progeny (GFAP+) were counted in a blinded manner as a percentage of the total number of neurospheres. Values represent mean ± SEM of two independent experiments (secondary and tertiary neurospheres) on 2 littermates for each genotype. way ANOVA, Bonferroni post-tests, ***: p<0.001. Note that in Figure 4 , the O4-positive neurospheres that were counted correspond to the sum of the Tuj1-positive/GFAP-positive/O4-positive and the GFAP-positive/O4-positive neurospheres.
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25 Figure S7 . Validation of the differences in gene expression for selected genes differentially regulated between FoxO3 -/-and FoxO3 +/+ NSC RT-qPCR analysis of RNA from FoxO3 -/-and FoxO3 +/+ secondary neurospheres from 3 month-old mice with primers to specific genes. The results are normalized by β-actin expression. Values represent mean ± SEM of two independent samples conducted in triplicate. These results were also observed in an independent experiment. Student's t-test, *: p<0.05. Figure S8 . FoxO3-regulated genes are enriched for genes expressed in cell quiescence, hypoxia, and aging (A) Gene set enrichment analysis plot for FoxO3-regulated genes and genes expressed in quiescent cells (Chang et al., 2004 and genes expressed in hypoxic astrocytes and HeLa cells (Mense et al., 2006 (Lu et al., 2004 
